$45.61
-0.65-1.41%
In chiusura: Aug 28, 5:00 PM EST
$45.60
-0.01-0.02%
Post-mercato: Aug 28, 7:59 PM EST
Novo Nordisk AS
NVONYSE
Novo Nordisk Earnings & Forecasts
Novo Nordisk (NVO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Novo Nordisk Guidance
Novo Nordisk (NVO) ha pubblicato l'ultima guidance il maggio 6, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $42.39B - $46.24B per il periodo.
Rispetto alle previsioni precedenti, Novo Nordisk ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Novo Nordisk ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Novo Nordisk. 15
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.81 | $0.87 | $0.89 | $0.77 |
| Actual | $0.96 | $1.04 | $1.00 | $1.03 |
| Surprise | +18.6% | +19.3% | +12.4% | +33.4% |
| Revenue | ||||
| Estimate | $11.35B | $11.13B | $12.08B | $11.88B |
| Actual | $12.21B | $15.17B | $12.34B | $11.74B |
| Surprise | +7.57% | +36.3% | +2.11% | -1.14% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.80 | $0.72 | $0.91 | $0.92 |
| Revenue | ||||
| Consensus | $11.47B | $12.17B | — | — |